49 results
424B3
ATXI
Avenue Therapeutics Inc
10 May 24
Prospectus supplement
4:53pm
pathways, which are involved in protecting cells from oxidative stress that can lead to cell death.
AJ201 is currently being studied in a Phase 1b/2a … increase in the authorized number of directors or the death, resignation, retirement, disqualification, removal from office or other cause
424B5
ATXI
Avenue Therapeutics Inc
10 May 24
Prospectus supplement for primary offering
4:52pm
are involved in protecting cells from oxidative stress that can lead to cell death. AJ201 is currently being studied in a Phase 1b/2a multicenter
424B3
ATXI
Avenue Therapeutics Inc
2 Feb 24
Prospectus supplement
12:00am
in the authorized number of directors or the death, resignation, retirement, disqualification, removal from office or other cause will be filled by a majority
424B4
6uk ho7am
2 Nov 23
Prospectus supplement with pricing info
9:00am
FWP
p4qx9jwnfhsuy1lnn gl
5 Oct 23
Free writing prospectus
5:05pm
FWP
zt88qemml1qth 5o
3 Oct 23
Free writing prospectus
5:47pm
8-K
EX-10.1
yj4i k2npm3n42
5 Jul 23
Departure of Directors or Certain Officers
4:15pm
424B3
t3jx9ijs
28 Jun 23
Prospectus supplement
4:56pm
424B3
0fm73y31h 3u7i3q41hj
4 May 23
Prospectus supplement
4:30pm